In addition to monitoring the expression of TERT and DNMT1 to predict sensitivity to decitabine in gliomas, the miRNA-DNMT1 axis plays an essential role in drug resistance and could be applied to overcome azacitidine resistance. This evidence concerns the gene DNMT1 and central nervous system cancer.